Dual/pan-HER tyrosine kinase inhibitors: focus in breast cancer

Adv Exp Med Biol. 2006:587:329-40. doi: 10.1007/978-1-4020-5133-3_25.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Breast Neoplasms / drug therapy*
  • ErbB Receptors / antagonists & inhibitors*
  • Humans
  • Lapatinib
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*
  • Receptor, ErbB-2 / antagonists & inhibitors*
  • Signal Transduction / drug effects

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Lapatinib
  • ErbB Receptors
  • Receptor, ErbB-2